Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Le Bris

Showing results (381-390 of 387) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 387 results.
Leukemia|April 1, 2025
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric studyLucile Bussot, Stéphanie Poulain, Morgane Nudel Ortmans, et al.
Nature Communications|August 7, 2024
Human genetic structure in Northwest France provides new insights into West European historical demographyIsabel Alves, Joanna Giemza, Michael G B Blum, et al.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
Nature Ecology & Evolution|November 26, 2020
A decade to study deep-sea lifeKerry L Howell, Ana Hilário, A Louise Allcock, et al.
Oncologie (Paris, France)|July 21, 2015
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (<i>Observatoire dédié au Cancer Bretagne / Pays de la Loire</i>)J P Metges, M A Lebot, R Faroux, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Physical Review Letters|September 28, 2010
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experimentK Aamodt, N Abel, U Abeysekara, et al.
Pageof 39

Showing results (381-390 of 387) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 387 results.
Leukemia|April 1, 2025
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric studyLucile Bussot, Stéphanie Poulain, Morgane Nudel Ortmans, et al.
Nature Communications|August 7, 2024
Human genetic structure in Northwest France provides new insights into West European historical demographyIsabel Alves, Joanna Giemza, Michael G B Blum, et al.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
Nature Ecology & Evolution|November 26, 2020
A decade to study deep-sea lifeKerry L Howell, Ana Hilário, A Louise Allcock, et al.
Oncologie (Paris, France)|July 21, 2015
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (<i>Observatoire dédié au Cancer Bretagne / Pays de la Loire</i>)J P Metges, M A Lebot, R Faroux, et al.
Leukemia|April 11, 2019
Exome sequencing identifies germline variants in DIS3 in familial multiple myelomaMaroulio Pertesi, Maxime Vallée, Xiaomu Wei, et al.
Physical Review Letters|September 28, 2010
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experimentK Aamodt, N Abel, U Abeysekara, et al.
Pageof 39